Literature DB >> 14518562

Inducible brain COX-2 facilitates the recurrence of hippocampal seizures in mouse rapid kindling.

Takako Takemiya1, Kyoko Suzuki, Hiroko Sugiura, Shin Yasuda, Kanato Yamagata, Yoriko Kawakami, Eiichi Maru.   

Abstract

Brain cyclooxygenase-2 (COX-2), the rate-limiting enzyme in prostaglandin synthesis, is rapidly and transiently induced by convulsions in hippocampal and cortical neurons. Therefore, we examined the effects of COX-2 on the 'rapid kindling' development in COX-2 knockout mice and in mice treated with nimesulide, a COX-2-selective inhibitor. Rapid kindling development was examined based on the incidence of hippocampal EEG seizures and behavioral seizures following repetitive electrical stimulation of the perforant path at an interval of 40 s, and on the total afterdischarge (AD) duration induced by 50 stimulations. In addition, we measured COX-2 mRNA expression by in situ hybridization and PGE2 concentration using enzyme immunoassay following rapid kindling stimulation. The results suggested that brain COX-2 mRNA levels were markedly increased in the hippocampal neurons and the concentration of PGE2 was elevated significantly, and that the incidence of AD and seizure behavior induction and the total AD duration were significantly decreased under conditions of COX-2 deficiency. Therefore, we concluded that inducible COX-2 facilitates the recurrence of hippocampal seizures.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14518562     DOI: 10.1016/s1098-8823(03)00040-6

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  22 in total

Review 1.  Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus.

Authors:  Yifeng Du; Timothy Kemper; Jiange Qiu; Jianxiong Jiang
Journal:  Expert Rev Neurother       Date:  2016-01-13       Impact factor: 4.618

2.  Platelet-activating factor receptor antagonism targets neuroinflammation in experimental epilepsy.

Authors:  Alberto E Musto; Mark Samii
Journal:  Epilepsia       Date:  2011-01-04       Impact factor: 5.864

Review 3.  Cyclooxygenase-2 in epilepsy.

Authors:  Asheebo Rojas; Jianxiong Jiang; Thota Ganesh; Myung-Soon Yang; Nadia Lelutiu; Paoula Gueorguieva; Raymond Dingledine
Journal:  Epilepsia       Date:  2013-11-08       Impact factor: 5.864

4.  Novel Targets for Developing Antiseizure and, Potentially, Antiepileptogenic Drugs.

Authors:  Dipan C Patel; Karen S Wilcox; Cameron S Metcalf
Journal:  Epilepsy Curr       Date:  2017 Sep-Oct       Impact factor: 7.500

5.  Prophylactic, prandial rofecoxib treatment lacks efficacy against acute PTZ-induced seizure generation and kindling acquisition.

Authors:  Robert J Claycomb; Sandra J Hewett; James A Hewett
Journal:  Epilepsia       Date:  2011-01-10       Impact factor: 5.864

6.  Angiotensin-(1-7)-induced plasticity changes in the lateral amygdala are mediated by COX-2 and NO.

Authors:  Doris Albrecht
Journal:  Learn Mem       Date:  2007-03-08       Impact factor: 2.460

7.  Anticonvulsant and hypnotic effects of amiodarone.

Authors:  Gunnur Ozbakis-Dengiz; Aysegul Bakirci
Journal:  J Zhejiang Univ Sci B       Date:  2009-04       Impact factor: 3.066

Review 8.  Pathophysiological Roles of Cyclooxygenases and Prostaglandins in the Central Nervous System.

Authors:  Tatsurou Yagami; Hiromi Koma; Yasuhiro Yamamoto
Journal:  Mol Neurobiol       Date:  2015-09-02       Impact factor: 5.590

Review 9.  Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside.

Authors:  Avijit Dey; Xu Kang; Jiange Qiu; Yifeng Du; Jianxiong Jiang
Journal:  Trends Pharmacol Sci       Date:  2016-04-06       Impact factor: 14.819

Review 10.  Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS.

Authors:  N Murataeva; A Straiker; K Mackie
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.